Fiera Capital Corp Sells 37,240 Shares of Danaher Corporation (NYSE:DHR)

Fiera Capital Corp decreased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 21.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 132,877 shares of the conglomerate's stock after selling 37,240 shares during the quarter. Fiera Capital Corp's holdings in Danaher were worth $27,240,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of DHR. Heck Capital Advisors LLC purchased a new stake in shares of Danaher during the fourth quarter worth $27,000. GHP Investment Advisors Inc. increased its position in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after purchasing an additional 99 shares during the last quarter. Sierra Ocean LLC raised its stake in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after purchasing an additional 76 shares in the last quarter. Hurley Capital LLC acquired a new stake in shares of Danaher during the 4th quarter valued at about $34,000. Finally, Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher in the 1st quarter valued at approximately $31,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Price Performance

NYSE:DHR traded down $2.61 during mid-day trading on Wednesday, hitting $204.24. 5,692,474 shares of the stock traded hands, compared to its average volume of 4,032,979. The business's 50-day moving average price is $196.69 and its 200 day moving average price is $203.24. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company has a market cap of $146.25 billion, a PE ratio of 43.46, a price-to-earnings-growth ratio of 2.87 and a beta of 0.77. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the company posted $1.72 EPS. Danaher's quarterly revenue was up 3.4% compared to the same quarter last year. On average, analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 25th. Shareholders of record on Friday, June 27th were issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.63%. Danaher's dividend payout ratio (DPR) is presently 27.23%.

Analyst Upgrades and Downgrades

Several research firms have commented on DHR. TD Cowen increased their target price on shares of Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research report on Wednesday, April 23rd. Leerink Partners lifted their target price on shares of Danaher from $225.00 to $230.00 and gave the stock an "outperform" rating in a report on Wednesday, April 23rd. Royal Bank Of Canada restated an "outperform" rating and set a $250.00 price target on shares of Danaher in a report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, Wolfe Research cut their target price on Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a research note on Monday, April 7th. Three equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $247.61.

Insider Activity at Danaher

In other news, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman owned 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 11.10% of the company's stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.